Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Carsten Snejbjerg"


2 mentions found


Ozempic Maker Novo Nordisk Has a Weight Problem
  + stars: | 2023-10-23 | by ( Stephen Wilmot | ) www.wsj.com   time to read: 1 min
Ozempic packets at a Novo Nordisk facility. When the company’s shares become more than 10% of Danish fund managers’ holdings, they are forced to sell. Photo: Carsten Snejbjerg/Bloomberg NewsThe company behind diabetes and obesity phenomena Ozempic and Wegovy is overweight. Novo Nordisk became Europe’s most valuable company last month, overtaking luxury goods maker LVMH, which itself took the title from food giant Nestlé in 2021. This might be a reason why the shares trade at a discount to those of its closest peer, U.S.-listed Eli Lilly .
Persons: Carsten Snejbjerg, Eli Lilly Organizations: Novo Nordisk, Bloomberg Locations: Novo, Danish
London CNN —Novo Nordisk has dethroned Bernard Arnault’s luxury goods giant LVMH as Europe’s most valuable company. At the close of trading Monday, Novo Nordisk (NVO) had a market capitalization of 2.96 trillion Danish krone ($428 billion). “We are just scratching the surface,” Novo Nordisk CEO Lars Fruergaard Jørgensen told CNN’s Meg Tirrell in a recent interview. Novo Nordisk has raked in almost 49 billion Danish krone ($7 billion) in profit over the first six months of this year, up 30% from the same period in 2022. Booming sales of its drugs have led to an influx of US dollars into Denmark’s economy, pushing up the value of the Danish krone.
Persons: Bernard, Wegovy, Louis Vuitton, Hennessy, , , Steve Barclay, Carsten Snejbjerg, Lars Fruergaard Jørgensen, CNN’s Meg Tirrell, , Organizations: London CNN — Novo Nordisk, Novo Nordisk, Louis, Health Service, Health, Social Care, Nordisk, Nordisk's, Bloomberg, Getty, World Health Organization, Danish krone, European Central Bank, Novo, UBS, Wegovy Locations: Danish, Ozempic, Wegovy, United States, Copenhagen, Denmark, Denmark’s, Novo Nordisk’s
Total: 2